Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: Time-course after acute myocardial infarction and stroke

Journal of Molecular and Cellular Cardiology

Volumn 80, Issue , 2015, Pages 146-155

  Regueiro, Ander ^a   Cuadrado Godia, Elisa ^b   Bueno Betí, Carlos ^c   Diaz Ricart, Maribel ^a   Oliveras, Anna ^d   Novella, Susana ^c   Gené, Gemma González ^b   Jung, Carole ^b   Subirana, Isaac ^f   Ortiz Pérez, Jose Tomás ^a   Roqué, Mercè ^a   Freixa, Xavier ^a   Núñez, Julio ^e   Escolar, Gines ^a   Marrugat, Jaume ^f   Hermenegildo, Carlos ^c   Valverde, Miguel Angel ^b   Roquer, Jaume ^b   Sanchis, Juan ^e   Heras, Magda ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

Cell adhesion molecule; Endothelial progenitor cell; Myocardial infarction; Stroke

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; VASCULOTROPIN A;

ACUTE DISEASE; ACUTE HEART INFARCTION; ADULT; ANGIOGENESIS; ARTICLE; CALCIUM TRANSPORT; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CIRCULATING ENDOTHELIUM CELL; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE PATIENT; AGED; CASE CONTROL STUDY; CELL CULTURE; CLINICAL TRIAL; DRUG EFFECTS; FOLLOW UP; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE; TIME;

ADULT; AGED; CASE-CONTROL STUDIES; CELL COUNT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 84923862966     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.01.005     Document Type: Article

References (36)

1. Lerman A., Holmes D.R., Herrmann J., Gersh B.J. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?. Eur Heart J 2007, 28:788-797.
2. Madden J.A. Role of the vascular endothelium and plaque in acute ischemic stroke. Neurology 2012, 79:S58-S62.
3. Boos C.J., Lip G.Y., Blann A.D. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 2006, 48:1538-1547.
4. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
5. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearny M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
6. Suarez de Lezo J., Herrera C., Romero M., Pan M., Suárez de Lezo J., Carmona M.D., et al. Functional improvement in patients with dilated cardiomyopathy after intracoronary infusion of autologous bone marrow mononuclear cells. Rev Esp Cardiol 2013, 66:450-457.
7. Boos C.J., Soor S.K., Kang D., Lip G.Y. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. Eur Heart J 2007, 28:1092-1101.
8. Boos C.J., Balakrishnan B., Blann A.D., Lip G.Y.H. The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis. J Thromb Haemost 2008, 6:1841-1850.
9. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
10. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:e1-e7.
11. Schmidt-Lucke C., Rössig L., Fichtlscherer S., Vasa M., Britten M., Kämper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
12. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
13. Sobrino T., Hurtado O., Moro M.A., Rodríguez-Yáñez M., Castellanos M., Brea D., et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007, 38:2759-2764.
14. Padfield G.J., Tura-Ceide O., Freyer E., Barclay G.R., Turner M., Newby D.E., et al. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease. Heart 2013, 99:791-798.
15. George J., Goldstein E., Abashidze S., Deutsch V., Shmilovich H., Finkelstein A., et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004, 25:1003-1008.
16. Michalska M., Machtoub L., Manthey H.D., Bauer E., Herold V., Krohne G., et al. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arterioscler Thromb Vasc Biol 2012, 32:2350-2357.
17. Lluis-Ganella C., Subirana I., Lucas G., Tomás M., Muñoz D., Sentí M., et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis 2012, 222:456-463.
18. Grau M., Subirana I., Elosua R., Solanas P., Ramos R., Masiá R., et al. Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil 2007, 14:653-659.
19. Freixa X., Masotti M., Palomo M., Diaz-Ricart M., Escolar G., Guasch E., et al. Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction. Microvasc Res 2011, 82:177-181.
20. Bueno-Betí C., Novella S., Lázaro-Franco M., Pérez-Cremades D., Heras M., Sanchis J., et al. An affordable method to obtain cultured endothelial cells from peripheral blood. J Cell Mol Med 2013, 17:1475-1483.
21. Fernandes J., Lorenzo I.M., Andrade Y.N., García-Elias A., Serra S.A., Fernández-Fernández J.M., et al. IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid. J Cell Biol 2008, 181:143-155.
22. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
23. Moniche F., Gonzalez A., Gonzalez-Marcos J., Carmona M., Piñero P., Espigado I., et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 2012, 43:2242-2244.
24. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105:199-206.
25. Yip H.K., Chang L.T., Chang W.N., Lu C.H., Liou C.W., Lan M.Y., et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008, 39:69-70.
26. Hibbert B., Simard T., Ramirez F.D., Pourdjabbar A., Raizman J.E., Maze R., et al. The effect of statins on circulating endothelial progenitor cells in humans: a systematic review. J Cardiovasc Pharmacol 2013, 62:491-496.
27. Sorrentino S.A., Doerries C., Manes C., Speer T., Dessy C., Lobysheva I., et al. Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. J Am Coll Cardiol 2011, 57:601-611.
28. Aird W. Phenotipic heterogeneity of the endothelium. Circ Res 2007, 100:174-190.
29. Cybulsky M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
30. Sucosky P., Balachandran K., Elhammali A., Jo H., Yoganathan A.P. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-ß1-dependent pathway. Arterioscler Thromb Vasc Biol 2009, 29:254-260.
31. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996, 93:672-682.
32. Vischer U.M. Von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006, 4:1186-1193.
33. Sánchez-Hernández Y., Laforenza U., Bonetti E., Fontana J., Dragoni S., Russo M., et al. Store-operated Ca(2+) entry is expressed in human endothelial progenitor cells. Stem Cells Dev 2010, 19:1967-1981.
34. Li J., Cubbon R.M., Wilson L.A., Amer M.S., McKeown L., Hou B., et al. Ora1 and CRAC channel dependence of VEFG-activated Ca(2+) entry and endothelial tube formation. Circ Res 2011, 13:1190-1198.
35. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
36. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularisation after cerebral ischemia. Am J Pathol 2000, 156:965-997.